# Perspective Therapeutics, Inc. (CATX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Perspective Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/CATX/mda/fy2025/): filed 2026-03-16; accession 0000728387-26-000004 (https://www.sec.gov/Archives/edgar/data/728387/000072838726000004/catx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/CATX/mda/fy2024/): filed 2025-03-26; accession 0000950170-25-045242 (https://www.sec.gov/Archives/edgar/data/728387/000095017025045242/catx-20241231.htm)
- [FY 2023 MD&A](/company/CATX/mda/fy2023/): filed 2024-03-28; accession 0001437749-24-009696 (https://www.sec.gov/Archives/edgar/data/728387/000143774924009696/isr20231231_10k.htm)
- [FY 2022 MD&A](/company/CATX/mda/fy2022/): filed 2022-09-28; accession 0001437749-22-023188 (https://www.sec.gov/Archives/edgar/data/728387/000143774922023188/isr20220630_10k.htm)
- [FY 2021 MD&A](/company/CATX/mda/fy2021/): filed 2021-09-27; accession 0001437749-21-022693 (https://www.sec.gov/Archives/edgar/data/728387/000143774921022693/isr20210630_10k.htm)

Back to /company/CATX/